Belfast, United Kingdom

Mark Garret

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Norbrook Laboratories Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Garret. Retrieved from https://idiyas.com/inventor/mark-garret

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Mark Garret

Introduction

Mark Garret is a notable inventor based in Belfast, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his work on the purification of meloxicam. His innovative approach has led to the development of a patented process that enhances the quality of this important medication.

Latest Patents

Mark Garret holds a patent for a process for the purification of meloxicam. This process involves purifying meloxicam form I from a crude meloxicam, ensuring a higher quality product for medical use. His patent reflects his commitment to improving pharmaceutical processes and patient outcomes.

Career Highlights

Garret is currently employed at Norbrook Laboratories Limited, a leading company in the veterinary pharmaceutical industry. His role at Norbrook has allowed him to apply his expertise in drug purification and contribute to the development of effective veterinary medications.

Collaborations

Throughout his career, Mark has collaborated with talented individuals such as Liam McElroy and Lillian Cromie. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Mark Garret's work exemplifies the impact of innovation in the pharmaceutical industry. His patented process for purifying meloxicam demonstrates his dedication to enhancing drug quality and efficacy. Through his career at Norbrook Laboratories Limited, he continues to make valuable contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…